Keywords: GLP-1, psoriasis, hidradenitis suppurativa, liraglutide, semiglutide Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are highly effective pharmacologic agents for managing type 2 diabetes (T2D) and obesity
The Wegovy pill is oral semaglutide at a 25 mg dose, from Novo
Figure 3 shows a spectrum of clinical appearances of subungual melanoma
Background and FDAs Announcement FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications, primarily semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound)
This warning is based on rodent studies showing increased risk, although no clear link has been found in humans
Description GHK-Cu is a tiny natural peptide just three amino acids that grabs onto copper